Global Peripheral Artery Disease Market To Be Driven By The Increasing Demand For Non-Invasive Procedures, Combined With The Population’s Unhealthy Lifestyle In The Forecast Period Of 2023-2028
The new report by Expert Market Research titled, ‘Global Peripheral Artery Disease Market Size, Share, Price, Trends, Growth, Report and Forecast 2023-2028’, gives an in-depth analysis of the Global Peripheral Artery Disease market, assessing the market based on its segments like application, end user, and major regions like North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Peripheral Artery Disease Market Share, Size, Trends, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2018-2028)
• Historical Market Size (2021): USD 3.82 billion
• Forecast CAGR (2023-2028): 8.5 %
• Forecast Market Size (2027): USD 5.26 billion
Asia Pacific is expected to have a substantial market share during the forecast period. A variety of factors are propelling the Asia Pacific peripheral artery disease sector forward. One of the major concerns is the large number of people who have untreated medical conditions like obesity, diabetes, and high blood pressure, which may increase the risk of peripheral artery disease.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/peripheral-artery-disease-market/requestsample
Furthermore, the region’s healthcare infrastructure has been growing faster than the GDP, which is expected to boost market growth during the forecast period. Furthermore, there have been some significant developments among the market’s major companies, which has increased global competition. In November 2020, Cardinal Health signed an agreement with the Centers for Disease Control and Prevention to serve as the official “network administrator” in phase 2 of the federal pharmacy partnership strategy for COVID-19. This collaboration is expected to broaden the company’s consumer base and, as a result, propel the peripheral artery disease market forward.
Peripheral Artery Disease Market Segmentation
Peripheral artery disease is a medical term that describes the constriction of arteries in the human body, which lowers blood flow to the lower body, including the legs. As a result, the oxygen and blood levels in the lower body drop below the required level, causing walking pain. Peripheral artery disease can potentially be a symptom of arterial blockage or congestion. This is normally addressed with a change in lifestyle, frequent exercise, and the discontinuation of all tobacco use.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/peripheral-artery-disease-market
Based on the major types, the market is divided into:
• Peripheral Angioplasty Balloons
• Peripheral Stents
• Peripheral Catheters
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Haemodynamic Flow Alteration Devices
• Peripheral Accessories
The regional markets for include:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
Peripheral Artery Disease Market Trends
The expanding health infrastructure has raised the use of interventional devices such as drug-eluting agents, atherectomy devices, and others, driving market expansion. Atherectomy is a procedure that uses a catheter to remove plaque from arteries, and its use in treating peripheral arterial disorders (PADs) has grown significantly. Furthermore, the demand for non-invasive or minimally invasive endovascular procedures has lately surged due to their faster recovery time and lower risk of post-surgery problems. Furthermore, the population’s unhealthy lifestyle, combined with increased intake of alcohol, tobacco, and smoking, may lead to an increase in the number of cardiac arrests, blood clotting, and other heart disorders in the coming years, increasing the need for PAD therapy.
The global aging population is expected to increase vulnerability to peripheral artery disorders in the future. Although the number of people aged 60 and up is expected to double by 2050, the number of people aged 80 and up is expected to triple between 2020 and 2050, according to WHO research published in October 2021. Aging is definitely related to an increase in the prevalence of medical disorders such as diabetes, high blood pressure, and heart disease, among others. This factor is expected to boost the peripheral artery disease market during the forecast period. Furthermore, mergers and acquisitions among the major market players have occurred, which are expected to play a significant role in market growth.
Key Market Players
The major players in the market are AngioDynamics Inc., B. Braun Melsungen AG, Biotronik Inc., Boston Scientific Corp., are among others.
The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
About Us :
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact :
Company Name: Claight Corporation
Contact Person: James Williams, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gloud Street, Sheridan, WY 82801, USA